Schweres Magnesiumoxid - Keresési eredmények

Európai Unió - izlandi - EMA (European Medicines Agency)

deferasirox accord

accord healthcare s.l.u. - deferasirox - iron overload; beta-thalassemia - Öllum öðrum lækninga vörur, járn klóbindlinum lyfjum - deferasirox hvötum er ætlað fyrir meðferð langvarandi járn of mikið vegna tíð blóðgjöf (stærri ml-7/kg/mánuði pakkað rauðum blóðkornum) í sjúklinga með beta thalassaemia helstu aldrinum 6 ára og eldri. deferasirox hvötum er einnig ætlað til meðferð langvarandi járn of mikið vegna blóðgjöf þegar deferoxamine meðferð er ekki ætlað eða ófullnægjandi í eftirfarandi sjúklingur tekur:í börn sjúklinga með beta thalassaemia helstu með járn of mikið vegna tíð blóðgjöf (stærri ml-7/kg/mánuði pakkað rauðum blóðkornum) aldrinum 2 til 5 ár,fullorðinn og börn sjúklinga með beta thalassaemia helstu með járn of mikið vegna fáum blóðgjöf (.

Európai Unió - izlandi - EMA (European Medicines Agency)

jyseleca

gilead sciences ireland uc, galapagos nv - filgotinib maleate - liðagigt, liðagigt - Ónæmisbælandi lyf - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

Európai Unió - izlandi - EMA (European Medicines Agency)

cibinqo

pfizer europe ma eeig - abrocitinib - dermatitis, atópísk - aðrar húðsjúkdómar - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.

Európai Unió - izlandi - EMA (European Medicines Agency)

kapruvia

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - Öll önnur lækningavörur - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

Európai Unió - izlandi - EMA (European Medicines Agency)

hemgenix

csl behring gmbh - etranacogene dezaparvovec - hemophilia b - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.

Európai Unió - izlandi - EMA (European Medicines Agency)

sotyktu

bristol-myers squibb pharma eeig - deucravacitinib - psoriasis - Ónæmisbælandi lyf - treatment of moderate-to-severe plaque psoriasis in adults.